Bio Rad Laboratories Stock Alpha and Beta Analysis
BIO-B Stock | USD 336.00 3.36 0.99% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bio Rad Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bio Rad over a specified time horizon. Remember, high Bio Rad's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bio Rad's market risk premium analysis include:
Beta (0.45) | Alpha 0.26 | Risk 301.43 | Sharpe Ratio 0.3 | Expected Return 91.17 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bio |
Bio Rad Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bio Rad market risk premium is the additional return an investor will receive from holding Bio Rad long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bio Rad. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bio Rad's performance over market.α | 0.26 | β | -0.45 |
Bio Rad Fundamentals Vs Peers
Comparing Bio Rad's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio Rad's direct or indirect competition across all of the common fundamentals between Bio Rad and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio Rad or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio Rad's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Bio Rad to competition |
Fundamentals | Bio Rad | Peer Average |
Return On Equity | -0.0979 | -0.31 |
Return On Asset | 0.0186 | -0.14 |
Profit Margin | (0.30) % | (1.27) % |
Operating Margin | 0.1 % | (5.51) % |
Current Valuation | 9.28 B | 16.62 B |
Shares Outstanding | 5.07 M | 571.82 M |
Shares Owned By Insiders | 97.96 % | 10.09 % |
Bio Rad Opportunities
Bio Rad Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
Timeline |
1 | Disposition of 430 shares by Andrew Last of Bio-Rad Laboratories at 4.6 subject to Rule 16b-3 | 03/04/2024 |
2 | Disposition of 253 shares by Timothy Ernst of Bio-Rad Laboratories subject to Rule 16b-3 | 04/19/2024 |
3 | Disposition of tradable shares by Ajit Ramalingam of Bio-Rad Laboratories at 4.6 subject to Rule 16b-3 | 08/02/2024 |
4 | Anyword Announces Gen-AI Performance Platform, First of Its Kind AI Solution for Marketers | 08/22/2024 |
5 | Bio-Rad Laboratories Inc Q3 2024 Earnings Call Highlights Strong Clinical Diagnostics ... | 10/31/2024 |
About Bio Rad Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bio or other stocks. Alpha measures the amount that position in Bio Rad Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 52.9 | 64.43 | 66.82 | 87.31 | PTB Ratio | 1.65 | 1.3 | 1.08 | 2.15 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.
Build Portfolio with Bio Rad
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Bio Rad technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.